Abstract:ABSTRACT Background Race is a social and not a biological construct. Major societies have recommended removing a race correction factor when estimating glomerular filtration rate (eGFR). eGFR is a strong predictor for acute kidney injury (AKI) after percutaneous coronary intervention (PCI). We assessed the effect of removal of the race correction factor in eGFR calculation on the predictive ability of contemporary models for AKI after PCI. Methods We used data from the American College of Cardiology’s National Cardiovascular Data Registry (NCDR) CathPCI registry to assess the effect of removing a race correction in eGFR calculation on two previously published AKI models developed using NCDR data – a logistic regression-based model and a gradient boosting machine learning (ML) model. We first assessed the calibration and discrimination of these models with and without race correction and subsequently included race as an independent predictor in a model without race-corrected eGFR. We assessed model performance overall, and stratified by Black and non-Black subgroups. The models were trained on the same cohort used to develop the NCDR models and validated with a contemporaneous validation data set. Results We included 947,091 PCI procedures in 915,223 patients (mean age 64.8 years; 7.9% were Black and 32.8% women) with an AKI rate of 7.4%. In the NCDR model, inclusion of race correction in eGFR significantly underestimated AKI risk among Black patients (predicted 7.6% vs observed 10.2%) while slightly overestimating risk among non-Black patients (predicted 7.4% vs observed 7.1%). Removing the race correction partially corrected the underestimation among Black patients (predicted 8.2%). Including race as an independent predictor and introducing interaction terms further reduced the underestimation (predicted 10.1%). The receiver-operating-characteristic curve (AUC) was similar among these models, but was consistently lower in Black patients. Compared with the logistic model, the ML model had better calibration in Black patients (with race correction predicted 8.6% and without 8.7%) but still underestimated AKI risk. With race included as a predictor, the ML model achieved similarly good calibration in Black patients (predicted 10.1%). The AUCs of ML models were better than the logistic models but did not differ based on the inclusion of the race correction. Conclusion Removing the race correction in eGFR calculation has a positive effect of reducing the underestimation of the risk of AKI following PCI for Black patients. However, despite the reduction in underestimation, Black patients remain at elevated risk for AKI compared to non-Black patients. There is a need to better capture the determinants of this higher AKI risk through richer data and advanced modeling techniques.

Evaluating the Effect of Estimating Renal Function With the CKD-EPI 2021 Equation on the ABCD-GENE Score for Clopidogrel Response Prediction

Effectiveness of Clopidogrel vs Alternative P2Y12 Inhibitors Based on the ABCD-GENE Score

Impact of the 2021 CKD-EPI equation on anticancer pharmacotherapy in black and non-black cancer patients

Effect of removing race correction factor in glomerular filtration rate estimation on predicting acute kidney injury after percutaneous coronary intervention

Impact of switching from the 2009 to the 2021 CKD-EPI Equation for eGFR

National Estimates of CKD Prevalence and Potential Impact of Estimating Glomerular Filtration Rate Without Race

Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE Trial

Impact of Removing Race Adjustment When Estimating GFR on Chronic Kidney Disease Staging

Race-modified estimated glomerular filtration rate underestimates chronic kidney disease prevalence in Black patients undergoing partial and radical nephrectomy: Implications for surgical planning

Utility of the ACD-GENE-CLI Score in Asian Patients with Critical Limb Ischemia Undergoing Endovascular Interventions

Comparison of Race-Based and Non-Race-Based Glomerular Filtration Rate Equations for the Assessment of Renal Functional Risk Before Nephrectomy

The New Creatinine-Based Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2021 Equation: Potential Impact on Screening for Chronic Kidney Disease in an Asymptomatic Black African Population

Algorithmic Changes Are Not Enough: Evaluating the Removal of Race Adjustment from the eGFR Equation

Prognostic impact of switching to the 2021 chronic kidney disease epidemiology collaboration creatinine-based equation in Caucasian patients with type 2 diabetes: the Renal Insufficiency and Cardiovascular events (RIACE) Italian Multicenter Study

2009 CKD-EPI glomerular filtration rate estimation in Black individuals outside the United States: a systematic review and meta-analysis

Eligibility for pharmacological therapies in heart failure with reduced ejection fraction: implications of the new Chronic Kidney Disease Epidemiology Collaboration creatinine equation for estimating glomerular filtration rate

The CKD-EPI 2021 Equation and Other Creatinine-Based Race-Independent eGFR Equations in Chronic Kidney Disease Diagnosis and Staging

CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention

The Implication of Dropping Race from the MDRD Equation to Estimate GFR in an African American-Only Cohort

Comparison of three creatinine-based equations to predict adverse outcome in a cardiovascular high-risk cohort: an investigation using the SPRINT research materials

Performance of Future Glomerular Filtration Rate Equation by Race in a Large, Racially Diverse Patient Cohort Undergoing Nephrectomy for Renal Cell Carcinoma